BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32003289)

  • 1. Hemoperfusion with Cytosorb in pediatric patients with septic shock: A retrospective observational study.
    Bottari G; Guzzo I; Marano M; Stoppa F; Ravà L; Di Nardo M; Cecchetti C
    Int J Artif Organs; 2020 Sep; 43(9):587-593. PubMed ID: 32003289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study.
    Hawchar F; László I; Öveges N; Trásy D; Ondrik Z; Molnar Z
    J Crit Care; 2019 Feb; 49():172-178. PubMed ID: 30448517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb.
    Zuccari S; Damiani E; Domizi R; Scorcella C; D'Arezzo M; Carsetti A; Pantanetti S; Vannicola S; Casarotta E; Ranghino A; Donati A; Adrario E
    Blood Purif; 2020; 49(1-2):107-113. PubMed ID: 31434083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.
    Friesecke S; Stecher SS; Gross S; Felix SB; Nierhaus A
    J Artif Organs; 2017 Sep; 20(3):252-259. PubMed ID: 28589286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb
    Singh YP; Chhabra SC; Lashkari K; Taneja A; Garg A; Chandra A; Chhabra M; Singh GP; Jain S
    Int J Artif Organs; 2020 Jun; 43(6):372-378. PubMed ID: 31868078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Hemoperfusion With CytoSorb Associated With Continuous Kidney Replacement Therapy on Renal Outcome in Critically III Children With Septic Shock.
    Bottari G; Lorenzetti G; Severini F; Cappoli A; Cecchetti C; Guzzo I
    Front Pediatr; 2021; 9():718049. PubMed ID: 34504817
    [No Abstract]   [Full Text] [Related]  

  • 7. The Clinical and Laboratory Efficacy of HA 330 Treatment Combined with Continuous Renal Replacement Therapy in Septic Shock Patients: A Case Series.
    Onuk S; Akin AK; Sari A; Gundogan K; Baskol G; Dogru K; Sungur M
    Blood Purif; 2023; 52(2):140-147. PubMed ID: 36634624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial.
    Kanjo A; Molnar Z; Zádori N; Gede N; Erőss B; Szakó L; Kiss T; Márton Z; Malbrain MLNG; Szuldrzynski K; Szrama J; Kusza K; Kogelmann K; Hegyi P
    BMJ Open; 2021 Aug; 11(8):e050464. PubMed ID: 34446497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoadsorption by CytoSorb in septic patients: a case series.
    Kogelmann K; Jarczak D; Scheller M; Drüner M
    Crit Care; 2017 Mar; 21(1):74. PubMed ID: 28343448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Effects and Outcomes After Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates.
    Nishizaki N; Hara T; Obinata K; Nakagawa M; Shimizu T
    Pediatr Crit Care Med; 2020 Feb; 21(2):156-163. PubMed ID: 31568052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational case series: six neurosurgical patients with septic shock demonstrating clinical improvement after a combination of standard care and blood purification.
    Burov AI; Abramov TA; Kostritca NS; Korotkov DS; Danilov GV; Strunina YV; Savin IA
    Eur J Med Res; 2021 Dec; 26(1):151. PubMed ID: 34930484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of HA330 Hemoperfusion Adsorbent in Patients Followed in the Intensive Care Unit for Septic Shock and Acute Kidney Injury and Treated with Continuous Venovenous Hemodiafiltration as Renal Replacement Therapy.
    Kaçar CK; Uzundere O; Kandemir D; Yektaş A
    Blood Purif; 2020; 49(4):448-456. PubMed ID: 31991412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience.
    Calabrò MG; Febres D; Recca G; Lembo R; Fominskiy E; Scandroglio AM; Zangrillo A; Pappalardo F
    Artif Organs; 2019 Feb; 43(2):189-194. PubMed ID: 30156308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoadsorption treatment with CytoSorb
    Träger K; Skrabal C; Fischer G; Schroeder J; Marenski L; Liebold A; Reinelt H; Datzmann T
    Int J Artif Organs; 2020 Jun; 43(6):422-429. PubMed ID: 31868089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber.
    Nakamura T; Ebihara I; Shimada N; Koide H
    Intensive Care Med; 1998 Dec; 24(12):1272-6. PubMed ID: 9885879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Blood Purification by HA330 as Adjunctive Treatment in Children with Septic Shock.
    Siripanadorn T; Samransamruajkit R
    Blood Purif; 2023; 52(6):549-555. PubMed ID: 37231783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study.
    Bottari G; Guzzo I; Cappoli A; Labbadia R; Perdichizzi S; Serpe C; Creteur J; Cecchetti C; Taccone FS
    Front Pediatr; 2023; 11():1259384. PubMed ID: 37780052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the timing and intensity of treatment on septic shock patients treated with CytoSorb
    Berlot G; Samola V; Barbaresco I; Tomasini A; di Maso V; Bianco F; Gerini U
    Int J Artif Organs; 2022 Mar; 45(3):249-253. PubMed ID: 35075942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival Analysis.
    Brouwer WP; Duran S; Ince C
    Blood Purif; 2021; 50(4-5):539-545. PubMed ID: 33352555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.